CosmosSynthetic biology presents an ethical tightrope | CosmosCosmosSynthetic biology is a descendant of recombinant DNA (rDNA) technology, which transformed biology in the 1970s by allowing scientists to cut and paste DNA from one organism to another… Continue reading
CosmosLife 2.0: inside the synthetic biology revolutionCosmosImagine a future where synthetic jellyfish roam waterways looking for toxins to destroy, where eco-friendly plastics and fuels are harvested from vats of yeast, where viruses are programmed t… Continue reading
CosmosLife 2.0: inside the synthetic biology revolutionCosmosImagine a future where synthetic jellyfish roam waterways looking for toxins to destroy, where eco-friendly plastics and fuels are harvested from vats of yeast, where viruses are programmed t… Continue reading
GenomeWebBioinformatics Pipeline Annotates CRISPR Repeats, Cas Genes; Assembles Data in One RepositoryGenomeWebIndeed, barely a month ago, early-stage life sciences company Arbor Biotechnologies and the team of Patrick Hsu at the Salk Institute for Bio… Continue reading
CRISPRdisco Pipeline IDs, Annotates CRISPR Repeats, Cas Genes; Assembles Data in One RepositoryGenomeWebIndeed, barely a month ago, early-stage life sciences company Arbor Biotechnologies and the team of Patrick Hsu at the Salk Institute for Biological… Continue reading
Genetic Engineering & Biotechnology NewsSynthetic Nucleotides Improve CRISPR-Cas9 Specificity 10000-FoldGenetic Engineering & Biotechnology NewsScientists at the University of Alberta in Canada have developed a technology that can dramatically improve … Continue reading
|
DiaCarta, MIODx to Codevelop Diagnostic to Predict Immunotherapy Response
GenomeWeb NEW YORK (GenomeWeb) – DiaCarta and MIODx today said they plan to codevelop a diagnostic test to predict immunotherapy response based on MIODx’s immune sequencing technology, ClonoMap. The test will be developed and validated at DiaCarta’s CLIA … DiaCarta and MIODx Join Forces to Develop a Diagnostic Test to Predict Patient Responses to ImmunotherapyBusiness Wire (press release) |